Recently it has been found that General Control Non-derepressible 2 (GCN2) can be activated by an array of small molecule ATP-competitive inhibitors, including clinically relevant compounds such as Ponatinib, and compounds specifically designed to be GCN2 inhibitors, such as GCN2iB. Furthermore, we recently showed that GCN2 can be activated in cells by clinically approved small molecule RAF inhibitors. GCN2 is a drug target, specifically in cancers such as mesothelioma, and a better understanding of this paradoxical activation is required to develop drugs which truly inhibit the enzyme. Using biochemical assays and structural mass spectrometry, we present a model for how GCN2 is activated by these compounds by promoting an active conformation in the HisRS domain while competitively inhibiting the kinase domain. This conformation promotes activating phosphorylation of GCN2, potentially through phosphorylation of other activated GCN2 molecules which are not bound to compound. Together this model suggests that efforts to inhibit GCN2 would benefit from exploring allosteric routes rather than targeting the ATP-binding pocket of the kinase domain.
The maturation of the RNA cap involving guanosine N-7 methylation, catalyzed by the HsRNMT (RNA guanine-7 methyltransferase)-RAM (RNA guanine-N7 methyltransferase activating subunit) complex, is currently under investigation as a novel strategy to combat PIK3CA mutant breast cancer. However, the development of effective drugs is hindered by a limited understanding of the enzyme’s mechanism and a lack of small molecule inhibitors. Following the elucidation of the Hs RNMT-RAM molecular mechanism, we report the biophysical characterization of two small molecule hits. Biophysics, biochemistry and structural biology confirm that both compounds bind competitively with cap and bind effectively to Hs RNMT-RAM in the presence of the co-product SAM, with a binding affinity (K D ) of approximately 1 μM. This stabilisation of the enzyme-product complex results in uncompetitive inhibition. Finally, we describe the properties of the cap pocket and provided suggestions for further development of the tool compounds.
Vacuolar sorting receptors (VSRs) are type I membrane proteins crucial for seed germination and plant development. Although VSR trafficking has been extensively studied, the mechanism of cargo recognition and release by the N-terminal lumenal region remains poorly understood. Here, we solved the crystal structures of both unloaded and cargo-loaded forms of the VSR1 lumenal region comprising the protease-associated (PA) domain, the Central domain and epidermal growth factor-like repeats. Two cargo binding sites were identified: one previously reported site found in the PA and Central domains and one uncharacterised site located within the Central domain. The large conformational differences observed between the two crystal structures are confirmed in solution by Small-angle X-ray scattering (SAXS) experiments. Their combination revealed that calcium coordination remodels inter-domain linkers, triggering large conformational changes that expose and remodel the two cargo binding sites. Complementary X-ray footprinting mass spectrometry (XFMS) mapped the residues undergoing solvent accessibility changes induced by cargo binding and confirmed residues affected in both cargo binding sites and across all three domains in solution. Together, these findings reveal a dynamic calcium-dependent mechanism in which high calcium concentrations promote cargo binding, while cargo release is favoured by lower calcium concentrations and pH. This work provides a structural framework for understanding VSR-mediated vacuolar trafficking and cargo sorting in plants.